Commentary: “Käytännöllistelemälläkin”: Antiaggregants, anticoagulants, and endocarditisCentral Message
Main Author: | Ari A. Mennander, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | JTCVS Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266627362100423X |
Similar Items
-
Commentary: Collective responsibility in combating injection drug use-related endocarditisCentral Message
by: Ari A. Mennander, MD, PhD
Published: (2021-12-01) -
Poor long-term outcomes of intravenous drug users with infectious endocarditisCentral MessagePerspective
by: Juan Caceres, MD, et al.
Published: (2022-09-01) -
The opioid epidemic and endocarditis: Frontiers in the management of injection drug use–related endocarditisCentral Message
by: Makoto Mori, MD, et al.
Published: (2021-12-01) -
The role of antiaggregant agents and anticoagulants in the prevention of aortic valve endocarditis: A double-cohort retrospective studyCentral MessagePerspective
by: Hanne Theys, MD, et al.
Published: (2021-12-01) -
Commentary: A pile of vital cells is needed to treat myocardial infarctionCentral Message
by: Ari A. Mennander, MD, PhD
Published: (2021-12-01)